Visterra

About:

Visterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.

Top Investors: Temasek Holdings, Alexandria Venture Investments, MRL Ventures Fund, Vertex Ventures, Bill & Melinda Gates Foundation

Description:

Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.

Total Funding Amount:

$125M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)visterrainc.com

Founders:

Kevin Bitterman, Ram Sasisekharan

Number of Employees:

51-100

Last Funding Date:

2017-10-05

IPO Status:

Private

Industries: